市场调查报告书
商品编码
1618256
乳房植入:市场洞察·竞争环境·市场预测 (~2030年)Breast Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
乳房植入物市场规模预计将从 2023 年的 18 亿美元增长到 2030 年的 27 亿美元,预测期内复合年增长率为 7.00%。
由于乳癌患者数量的增加、产品开发活动的增加、乳房重建和整容手术的增加以及各种乳房植入物的可用性等因素,该市场正在经历显着增长。
乳房植入物:市场动态
根据 Globocan 2024 的数据,全球有 2,296,840 人被诊断出罹患乳癌。此外,同一来源报告称,亚洲有 985,817 名乳癌患者,欧洲有 557,532 名乳癌患者,非洲有 198,553 名乳癌患者。全球乳癌的高发生率推动了对乳房重建方案(包括植入物)的需求,因为许多患者在乳房切除术后寻求重建手术。
主要参与者的各种产品开发活动预计也将进一步提振市场。
按产品类型划分,盐水乳房植入物预计将在 2023 年占据重要的市场占有率。这是由于与盐水乳房植入物相关的各种特征。
盐水植入物通常被认为在破裂的情况下更安全,因为身体可以吸收盐水而不会产生副作用。这种安全优势在严格的监管标准优先考虑病人安全的市场中尤为重要,有助于提高采用率。
此外,由于盐水植入物在插入后会被填充,因此插入时所需的切口较少,这对寻求疤痕较少的微创手术的患者很有吸引力。此外,盐水植入物设计的进步,例如改进的外壳技术和可调节的体积选项,提高了耐用性、美观效果和可自订性,使其成为对患者和外科医生都有吸引力的选择。
本报告提供全球乳房植入的市场调查,彙整市场概要,市场影响因素及市场机会分析,法律制度,市场规模的转变·预测,各种区分·地区/各主要国家的详细分析,竞争情形,主要企业简介等资讯。
Breast Implants Market by Product Type (Silicone Breast Implants and Saline Breast Implants), Shape (Round and Anatomical), Texture (Smooth and Textured), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of breast cancer and rising product developmental activities across the globe
The breast implants market was valued at USD 1.80 billion in 2023, growing at a CAGR of 7.00% during the forecast period from 2024 to 2030 to reach USD 2.70 billion by 2030. The breast implants market is experiencing significant growth due to the increasing instances of breast cancer, rising product developmental activities, rise in breast reconstructive and cosmetic surgeries, and the availability of a wide variety of breast implants that are acting as major factors contributing to the overall growth of the breast implants market during the forecast period from 2024 to 2030.
Breast Implants Market Dynamics:
According to Globocan 2024, it stated that globally 2,296,840 were affected by breast cancer. Furthermore, the same source stated that Asia accounted for 985,817 breast cancer cases, Europe accounted for 557,532 breast cancer cases, and Africa accounted for 198,553 breast cancer cases. The high global incidence of breast cancer is driving demand for breast reconstruction options, including implants, as many patients seek reconstructive surgery post-mastectomy. This trend is expanding the market for breast implants, supporting physical and emotional recovery for survivors.
Various product developmental activities by the key market players will further boost the market for the same. For instance, in September 2024, GC Aesthetics(R) (GCA), a leading medical technology company committed to advancing women's health through innovative aesthetic and reconstructive breast solutions, announced the launch of the YOUTHLY(TM) brand in China, featuring its latest breast implant innovations; PERLE(TM), Luna XT(TM), and the latest version of The Round Collection(TM), 100% filled.
Additionally, in August 2024, CollPlant and Stratasys announced the pre-clinical study for regenerative breast implants with 200cc commercial-sized regenerative implants printed on a Stratasys Origin 3D printer.
Hence, the interplay of all the above-mentioned factors is expected to drive the breast implant market during the given forecast period from 2024 to 2030.
However, the potential risks associated with breast implants, the high cost associated with breast augmentation procedures, and others may restrict the market growth for the breast implants market.
Breast Implants Market Segment Analysis:
Breast Implants Market by Product Type (Silicone Breast Implants and Saline Breast Implants), Shape (Round and Anatomical), Texture (Smooth and Textured), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the breast implants market, saline breast implants are anticipated to hold a significant market share in the year 2023. This is due to various features associated with saline breast implants.
Saline implants are generally considered safer in cases of rupture, as the body can absorb the saline solution without adverse effects. This safety advantage is particularly important in markets where stringent regulatory standards prioritize patient safety, contributing to higher adoption rates.
Additionally, saline implants require a smaller incision for insertion, as they are filled after placement, which appeals to patients seeking minimally invasive procedures with reduced scarring. Furthermore, advancements in saline implant design, such as improved shell technology and adjustable volume options, have enhanced their durability, aesthetic outcomes, and customization, making them an attractive option for both patients and surgeons.
Additionally, in May 2024, Bimini Health Tech assembled a comprehensive portfolio incorporating the Serene structured saline breast implant, an Acellular Dermal Matrix (ADM), and the Puregraft family of fat transfer products.
Therefore, the widespread uses and various advantages of saline breast implant that enhance performance and usability, solidifying a significant impact on the growth of the overall breast implants market during the forecast period from 2024 to 2030.
North America is expected to dominate the overall breast implant market:
Among all the regions, North America is estimated to hold a significant revenue share in the breast implant market. This can be attributed to several factors including the growing number of breast cosmetic surgeries and reconstruction procedures, increasing instances of breast cancer, and the continuous advancement of technology in this field, which offers improved treatment features and efficiency, acting as key factors that contribute to the growth of the breast implants market in the North America region during the forecast period from 2024 to 2030.
According to the American Society of Plastic Surgeons 2024, it stated that in 2022, there were about 304,181 breast augmentation procedures in the US. The same source further stated that about 157,740 breast reconstruction procedures happened in the year 2022. Thus, the growing number of breast cosmetic surgeries and reconstruction procedures is anticipated to surge the demand for breast implants in the region, thereby propelling the market for the same.
As per data from Globocan 2024, it stated that in the year 2022, 274,375 people in the US and 31,823 people in Canada were affected by breast cancer. The high incidence of breast cancer in the region is driving the demand for breast implants, as many patients seek reconstructive surgery post-treatment. This trend highlights a growing market for breast implants, with a focus on supporting patients' recovery and body confidence.
Various product developmental strategies by key players in the region play a major role in pushing forward the revenue shares of breast implants in the region. For example, in October 2021, AbbVie, a manufacturer of breast implants launched a breast cancer campaign to highlight reconstruction options among women. Moreover, product launches by key market players in the region is further expected to propel the growth of the North America breast implants market.
Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the breast implants market during the forecast period from 2024 to 2030.
Breast Implants Market key players:
Some of the key market players operating in the breast implants market include Johnson & Johnson Services, Inc., Hans BioMed., AbbVie Inc., IDEAL IMPLANT INCORPORATED, Sebbin, GC Aesthetics, POLYTECH Health & Aesthetics GmbH, SurgiSil, Silimed, CEREPLAS, Establishment Labs, and others.
Recent Developmental Activities in the Breast Implants Market:
Key takeaways from the Breast Implants market report study
Target audience who can be benefited from this Breast Implants market report study
Frequently Asked Questions for the Breast Implants Market: